IKZF1 and chronic myelogenous leukemia, BCR-ABL1 positive: A recent study linked IKZF1 and CDKN2A/B mutations in LBP to increased RAG activity and RAG-mediated events [37], suggesting RAG expression as a factor contributing to the transition to CML LBP.